Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)
Others
Ratios

BioNexus Gene Lab (BGLC) Other Non Operating Income (2019 - 2025)

Historic Other Non Operating Income for BioNexus Gene Lab (BGLC) over the last 6 years, with Q3 2025 value amounting to $107760.0.

  • BioNexus Gene Lab's Other Non Operating Income fell 7685.2% to $107760.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year decrease of 1844.42%. This contributed to the annual value of $2.1 million for FY2024, which is 32640.32% up from last year.
  • BioNexus Gene Lab's Other Non Operating Income amounted to $107760.0 in Q3 2025, which was down 7685.2% from $209461.0 recorded in Q2 2025.
  • In the past 5 years, BioNexus Gene Lab's Other Non Operating Income registered a high of $730105.0 during Q2 2024, and its lowest value of -$208468.0 during Q1 2021.
  • In the last 4 years, BioNexus Gene Lab's Other Non Operating Income had a median value of $99590.0 in 2025 and averaged $181532.7.
  • As far as peak fluctuations go, BioNexus Gene Lab's Other Non Operating Income plummeted by 12295.32% in 2021, and later surged by 6700.88% in 2022.
  • BioNexus Gene Lab's Other Non Operating Income (Quarter) stood at $38930.0 in 2021, then crashed by 276.67% to -$68776.0 in 2022, then soared by 1081.44% to $674994.0 in 2024, then plummeted by 84.04% to $107760.0 in 2025.
  • Its Other Non Operating Income was $107760.0 in Q3 2025, compared to $209461.0 in Q2 2025 and $91420.0 in Q1 2025.